Suchergebnisse - "Kaku, Kohei"

PubPharm (26)

1

Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice

enthalten in: Diabetes, obesity & metabolism | 2024

von Iwamoto, Y. | Kimura, T. | Dan, K. | +11

2

Case Report : Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid

enthalten in: Frontiers in immunology | 2022

von Iwamoto, Y. | Anno, T. | Koyama, K. | +6

3

Dipeptidyl peptidase-4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes

enthalten in: Journal of diabetes investigation | 2021

von Abe, T. | Matsubayashi, Y. | Muragishi, S. | +7

4

Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice

enthalten in: Scientific reports | 2021

von Fushimi, Y. | Obata, A. | Sanada, J. | +9

5

New prospects for incretin-related drugs in the treatment of type 2 diabetes

enthalten in: Journal of diabetes investigation | 2021

von Kimura, T. | Kaku, K.

6

A randomized, placebo-controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin

enthalten in: Diabetes, obesity & metabolism | 2021

von Seino, Y. | Kaku, K. | Kadowaki, T. | +6

7

Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes : a rapid evidence assessment and narrative synthesis

enthalten in: Expert opinion on drug safety | 2021

von Kadowaki, T. | Yamamoto, F. | Taneda, Y. | +5

8

Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus : A Retrospective Observational Study

enthalten in: Frontiers in endocrinology | 2021

von Sanada, J. | Kimura, T. | Shimoda, M. | +12

9

Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end-stage renal disease : Results from a randomized, phase 3 study

enthalten in: Journal of diabetes investigation | 2020

von Kaku, K. | Ishida, K. | Shimizu, K. | +2

10

Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus : A Retrospective Study

enthalten in: Journal of diabetes research | 2020

von Fushimi, Y. | Obata, A. | Sanada, J. | +16